Paul Burton
Chief Tech/Sci/R&D Officer bei AMGEN INC.
Vermögen: 101 658 $ am 31.03.2024
Profil
Dr. Paul Burton ist Chief Global Medical Affairs Officer bei Janssen Pharmaceuticals, Inc. Dr. Burton war zuvor als Vizepräsident bei Janssen Research & Development LLC beschäftigt. Er erwarb seinen Hochschulabschluss an der University of London und promovierte am Imperial College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MODERNA, INC.
0,00% | 07.11.2022 | 954 ( 0,00% ) | 101 658 $ | 31.03.2024 |
Aktive Positionen von Paul Burton
| Unternehmen | Position | Beginn |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01.06.2023 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Chief Tech/Sci/R&D Officer | 01.03.2020 |
| Royal College of Surgeons | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Paul Burton
| Unternehmen | Position | Ende |
|---|---|---|
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01.01.2023 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | - |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Ausbildung von Paul Burton
| Imperial College London | Doctorate Degree |
| University of London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| MODERNA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
